Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of the American Academy of Dermatology|June 4, 2019
Comparative safety of systemic immunomodulatory medications in adults with atopic dermatitisMaria C Schneeweiss, Lourdes Perez-Chada, Joseph F Merola
Lancet (London, England)|July 29, 2026
PsoriasisLihi Eder, Lourdes Perez-Chada, Wilson Liao, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2024
A Case Series of TNF Inhibitor-Induced Psoriasis Successfully Treated With UpadacitinibMichael J Woodbury, Carly Grant, Lourdes Perez-Chada, et al.
Research Square|January 10, 2024
The Impact of Hidradenitis Suppurativa on Health Care Decision Making and VaccinesNajiba Afzal, Marjorie Archila, John S Barbieri, et al.
The Journal of Clinical and Aesthetic Dermatology|December 19, 2025
Hidradenitis Suppurativa Patients Experience a Significant Musculoskeletal Symptom Burden: A Quality Improvement Initiative Using the IDEOM MSK-QSarah Romanelli, Gretchen D Ball, Hassan Hamade, et al.
Journal of the American Academy of Dermatology|September 17, 2019
Achieving consensus on patient-reported outcome measures in clinical practice for inflammatory skin disordersLourdes Perez-Chada, Vanina L Taliercio, Alice B Gottlieb, et al.
Journal of Drugs in Dermatology : JDD|August 7, 2025
Streamlining Psoriatic Arthritis Screening and Management Using the IDEOM Clinical Framework: A Quality Improvement InitiativeSarah Romanelli, Gretchen D Ball, Hassan Hamade, et al.
JAMA Dermatology|August 20, 2025
Comparative Risk of Infection and Prevalence of Combination Targeted Therapy in Psoriatic ArthritisAlexander Wu, Arianna Zhang, Yujia Guo, et al.
JID Innovations : Skin Science From Molecules to Population Health|August 16, 2024
Prevalence and Impact of Unacceptable Symptom State among Patients with Psoriatic Arthritis: Results from the National Psoriasis Foundation's 2019 Annual SurveyMelissa P Zundell, Alexis R Ogdie-Beatty, Lourdes Perez-Chada, et al.
Pageof 2